摘要 |
Compounds of the formula (I) wherein X is O, CH2, S or NH, or the moiety X-R<1> is hydrogen; V is CH or N; R<1> is hydrogen, C1-6alkyl, C3-7cycloalkyl, aryl, arylC1-6alkyl, heterocyclyl, hererocyclylC1-6alkyl, heteroaryl, or heteroarylC1-6alkyl any of which except hydrogen may be optionally substituted; R<2> and R<3> independently represent hydrogen, C1-6alkyl, C3-7cycloalkyl, aryl, arylC1-6alkyl, heteroaryl, heteroarylC1-6alkyl, heterocyclyl, or heterocyclylC1-6alkyl any one of which except hydrogen may be optionally substituted, or R<2> and R<3> together with the nitrogen atom to which they are attached form a 4- to 10- membered optionally substituted monocyclic or bicyclic ring; Ar is an aryl or heteroaryl ring either of which may be optionally substituted; one of X1 and X2 is N and the other is NR<4>, wherein R<4> is hydrogen, C1-6alkyl, or arylC1-6alkyl; or pharmaceutically acceptable salts thereof; their use as inhibitors of Raf kinases and pharmaceutical compositions containing them.
|
申请人 |
SMITHKLINE BEECHAM P.L.C.;GAIBA, ALESSANDRA;TAKLE, ANDREW, KENNETH;WILSON, DAVID, MATTHEW |
发明人 |
GAIBA, ALESSANDRA;TAKLE, ANDREW, KENNETH;WILSON, DAVID, MATTHEW |